Crossmark

Antiparasitic dibenzalacetone inhibits the GTPase activity of Rab6 protein of Leishmania donovani (LdRab6), a potential target for its antileishmanial effect

Crossref DOI link: https://doi.org/10.1007/s00436-020-06810-4

Published Online: 2020-08-04

Published Print: 2020-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chauhan, Indira Singh

Marwa, Simran

Rao, G. Subba

Singh, Neeloo https://orcid.org/0000-0001-6627-7449
Funding

Funding for this research was provided by:

Central Drug Research Institute
License Information

Text and Data Mining valid from 2020-08-04

Version of Record valid from 2020-08-04
More Information

Article History

Received: 31 March 2020

Accepted: 8 July 2020

First Online: 4 August 2020

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below